Study of depressive disorders in the patients infected by HIV

Introduction: Depression is the most common mental health problem for people with HIV/AIDS in Africa, the announcement of the disease, the binding processing; relational difficulties with the surroundings contribute to the installation of this mood disorder. The objective of our study is to identify the impact of depressive disorders in HIV infection in our patients. Methodology: This is a cross-sectional study at the center of excellence for 4 months. 50 patients adhere to treatment ARV since more than 6 months were submitted to a questionnaire specialized depression, Depression of Beck (BDI) inventory, informed consent was required. Results: 50 patients were part of our study with female 62% for a sex ratio F/H 1.6. 26% of the participants are officials compared to 74% of persons exercising a liberal profession, The predominant level of study is secondary or 68% of our patients. Compared assessment of depression by the BDI, 46% of patients showed signs of depression which 8% of our patients showed signs of major depression with a suicidality of 25% compared with 12% of average depression signs. Conclusion: Depressive disorders during HIV infection represent a real danger for the care of patients; several biopsychosocial factors can explain their occurrence. During our survey 46% of the participants showed signs of depression and among them 8% of major form with a rate of suicidality by 25%. Correspondence to: Katabwa Kabongo J, Department of Internal Medicine, University of Lubumbashi, Democratic Republic of the Congo, Tel: + 243 99 70 17 104; E-mail: joekabongo2004@gmail.com Received: October 01, 2016; Accepted: October 12, 2016; Published: October 17, 2016 Introduction HIV infection is now recognized as a chronic disease and binding treatment, fear of a deterioration in his State of health, the difficulty in establishing intimate relationships, are weighing on the shoulders of patients. Property that 2 people on 3 with HIV live in Sub-Sahelian Africa, [1] most of what we know about the relationship between HIV and depression comes from research conducted in North America and Europe, very few studies have been conducted in our midst. Depression is not a commonplace phenomenon in patients infected with HIV, but a real disease that deserves adequate support; it can obviously have an influence on the adherence to treatment and therefore on the quality and the life expectancy of patients. This is why all feelings of sadness, lack of courage, black idea must be communicated to the physician. Several etiological bio-psycho-social factors have been advanced to explain the emergence of a depressive mood disorder in patients with HIV. First, the psychological impact of the discovery of its serology, experience it through time and the progression of the disease once declared AIDS, affective reactions are extremely varied and depends on several factors including the personality of the patient, psychiatric history and the quality of the response of his emotional surroundings [2]. The consequences on the thymie can be transient or prolonged ranging from reactive depressive disorder to severe depressive States. Uncertainty over the evolution and the response to treatment, the consequences on sexuality and the fear of social exclusion appear also as important to take into account [3] dimensions. On a neurological level, the central nervous systems HIV neurotropism led to neuro-pathological changes particularly at the level of some grey matter structures. On the other hand, these patients show a decrease in the concentrations of tryptophan which, associated with a decrease in serotonin biosynthesis, led a drop in level of this neurotransmitter [4]. In the stages of the disease, endocrine, metabolic and neurological disorders can aggravate or induce a depressive disorder. Similarly, medications such as some anti-retroviral and corticosteroids can also present as adverse effect a disruption of the [4] thymie. The objective of our work is to identify the impact of depressive Katabwa Kabongo J (2016) Study of depressive disorders in the patients infected by HIV Volume 2(5): 225-228 Clin Res Trials, 2016 doi: 10.15761/CRT.1000151 disorders in HIV infection, more specifically to determine the incidence of depression and suicidality in our cohort of HIV-infected patients.